CERO

CERo Therapeutics Holdings, Inc. CERO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CERO LIMN XRTX OCEA GLMD NKGN BIVI ELAB BCTXZ MLEC
6M -99.16 % -94.56 % -37.85 % -85.71 % -53.83 % -80.00 % -86.36 % -68.93 % -61.76 % -95.24 %
YTD -99.93 % -84.34 % -53.63 % -99.83 % -74.00 % -92.76 % -93.56 % -96.31 % -70.23 % -96.08 %
1Y -99.91 % -84.34 % -51.56 % -99.84 % -71.51 % -92.22 % -93.18 % -96.50 % -70.23 % -95.99 %
3Y -100.00 % -84.34 % -91.74 % -99.99 % -99.19 % -99.12 % -99.80 % -99.99 % -70.23 % -96.60 %
5Y -100.00 % -84.34 % -98.08 % -99.99 % -99.87 % -99.12 % -99.91 % -99.99 % -70.23 % -96.72 %
10Y -100.00 % -84.34 % -98.08 % -99.99 % -99.94 % -99.12 % -99.06 % -99.99 % -70.23 % -96.72 %
From the beginning -100.00 % -84.34 % -98.08 % -99.99 % -99.97 % -99.12 % -99.63 % -99.99 % -70.23 % -96.72 %

Dividend

XORTX Therapeutics Inc.